Try our Advanced Search for more refined results

Verinata Health, Inc. et al v. Ariosa Diagnostics, Inc et al

  1. November 16, 2020

    Illumina Wants Calif. Court To Double $27M IP Win Over Roche

    Illumina Inc. has urged a California federal court to top off its $26.7 million patent infringement win against Roche Molecular Systems Inc. over prenatal testing technology with another $27 million in pre- and post-verdict damages.

  2. February 14, 2019

    Trials Group Of The Year: Weil

    Weil Gotshal & Manges LLP had a big year in 2018 with trial wins for Johnson & Johnson in the always-newsworthy talc litigation and for a giant grocery warehouser accused of divvying up the distribution market with a competitor, among others, landing it on Law360's list of Trials Groups of the Year.

  3. July 20, 2018

    Ariosa Can't Shake $27M Verdict In Illumina Prenatal IP Row

    A California federal judge on Thursday refused to toss a $27 million verdict against Roche unit Ariosa Diagnostics Inc. for infringing Illumina Inc.'s patents for at-home prenatal testing technology, but allowed Ariosa to continue selling two versions of its tests.

  4. June 08, 2018

    Ariosa Fights Sales Ban, Says It's Not An Illumina Competitor

    Ariosa and Illumina sparred in California federal court Friday over whether Ariosa should be barred from selling its prenatal tests after a jury found it infringed two patents and owed Illumina $27 million, with an Illumina attorney arguing the contention the two companies weren't competitors was "an argument for a dumb person."

  5. April 09, 2018

    Illumina Urges Court To Uphold Jury Verdict Against Ariosa

    Illumina Inc. on Friday urged a California federal judge to uphold a jury's $26.7 million verdict against genomics company Ariosa Diagnostics Inc. for infringing two prenatal testing technology patents, fighting Ariosa's wide-ranging request for relief.

  6. March 19, 2018

    Illumina Says Sales Ban Needed To Stop Ariosa Infringement

    Illumina Inc. asked a California federal judge to permanently stop Roche's Ariosa Diagnostics Inc. from using its patents for prenatal testing technology, arguing in a filing on Friday that Ariosa's parent company's clout could tarnish Illumina's testing reputation irreparably.

  7. January 25, 2018

    Illumina Wins $27M Prenatal Test IP Verdict Against Ariosa

    A California federal jury handed Illumina Inc a $26.7 million win against genomics company Ariosa Diagnostics Inc. on Thursday, finding Ariosa infringed two of its patents protecting prenatal testing technology.

  8. January 23, 2018

    Illumina, Ariosa Seek Tens Of Millions As IP Trial Ends

    Illumina and Ariosa Diagnostics delivered closing arguments Tuesday in their two-week-long California federal court trial over noninvasive fetal testing technology, with Illumina arguing its rival infringed two patents while Ariosa countered that the lawsuit breached their contract — and each side saying it was entitled to tens of millions in damages.

  9. January 09, 2018

    Ariosa, Illumina Spar Over Patent Timing In DNA Test Trial

    An attorney for Ariosa pressed a former Illumina scientist on whether an article describing Ariosa's prenatal testing method predated his patent protecting similar technology, in a bid to knock out infringement claims during the first day of testimony Tuesday in a California federal jury trial.

  10. January 08, 2018

    Genomics IP Trial Between Illumina And Ariosa Kicks Off

    A California federal jury trial over two DNA testing patents kicked off Monday with genomics company Illumina arguing that Ariosa Diagnostics' prenatal testing technology infringed its patents, while Ariosa countered that the patents are invalid and that Illumina owes it $17.5 million for breaching a licensing agreement.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!